Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential

Jason Wallach, Andrew B. Cao, Maggie M. Calkins, +16

Nature Communications

A non-hallucinogenic LSD analog with therapeutic potential for mood disorders

Vern Lewis, Emma M. Bonniwell, Janelle K. Lanham, +16

Cell Reports

Pharmacological Mechanism of the Non-hallucinogenic 5-HT_2A Agonist Ariadne and Analogs

Michael J. Cunningham, Hailey A. Bock, Inis C. Serrano, +14

ACS Chemical Neuroscience

Conformational selection guides β-arrestin recruitment at a biased G protein–coupled receptor

Andrew B. Kleist, Shawn Jenjak, Andrija Sente, +14

Science

Mu-opioid receptor selective superagonists produce prolonged respiratory depression

Nicholas J. Malcolm, Barbara Palković, Daniel J. Sprague, +5

iScience

Functional profiling of the G protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism

Pedro Rodriguez, Lauren J. Laskowski, Jean Pierre Pallais, +8

Journal of Biological Chemistry

DPP4-Truncated CXCL12 Alters CXCR4/ACKR3 Signaling, Osteogenic Cell Differentiation, Migration, and Senescence

Ahmed M. Elmansi, Nada H. Eisa, Sudharsan Periyasamy‐Thandavan, +16

ACS Pharmacology & Translational Science

Identification of 5-HT _2A Receptor Signaling Pathways Responsible for Psychedelic Potential

Jason Wallach, Andrew B. Cao, Maggie M. Calkins, +16